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Background: The risk of allergic diseases among Kawasaki disease (KD) patients relative to the general population
is not known. The aim of this study was to perform a population-based cohort study to investigate the risk of
allergic diseases among children after KD in Taiwan- a country with the third highest incidence of KD in the world.
Methods: Data were obtained from the Taiwan National Health Insurance Research Database. In total, 253 patients
who were 5 years of age or younger and had a first-time hospitalization with a diagnosis of KD between 1997 and
2005 were included as the study cohort and 1,012 non-KD patients matched for age and sex were included as
comparison cohort. Multivariate Cox proportional hazard regression model was used to adjust for confounding and
to compare the 6-year allergic-free survival rate between these two cohorts.
Results: The incidence rate of allergic diseases (184.66 per 1000 person-year) was significantly higher in the KD
cohort than in the control cohort (124.99 per 1000 person-years). After adjusting for potential confounders, the
adjusted hazard ratios of asthma and allergic rhinitis were 1.51 (95% confidence interval = 1.17-1.95) and 1.30
(95% confidence interval = 1.04-1.62), respectively.
Conclusion: We conclude that KD patients were at an increased risk for allergic diseases compared with the
comparison cohort.
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Kawasaki disease (KD) is an acute febrile systemic vascu-
litis that was first described by Kawasaki et al. in 1974 [1].
In developed countries, it is the leading cause of acquired
heart disease in children but its etiology remains unknown
[2-4]. This acute illness presents with systemic inflamma-
tion and occurs with fever lasting at least 5 days, with con-
junctival and oral mucosa changes, fissured lips, cervical
lymphadenopathy, skin rash, and palm/sole erythema/in-
duration [5,6]. The most serious complication of KD is the
presence of coronary artery lesions (CAL), including myo-
cardial infarction, coronary artery fistula formation [7], cor-
onary artery dilatation, and coronary artery aneurysm* Correspondence: chunyuh@kmu.edu.tw
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reproduction in any medium, provided the or(CAA) [8,9]. Children aged less than 5 years of age are the
most susceptible population. According to recent epidemi-
ologic studies, Asian populations have a much higher inci-
dence of KD. Japan has the highest annual incidence in the
world [10], followed by Korea and Taiwan (218, 113 and 69
per 100,000 children aged < 5 years of age, respectively)
[11,12]. The incidence of KD has increased globally in re-
cent years [9,10,13-15].
It has been reported that the prevalence of atopic derma-
titis among children with KD was 9 times greater than that
of controls [16]. A Japanese cross-sectional survey reported
that atopic dermatitis and/or allergic rhinitis were more
common in KD-affected children when compared to the
non-KD controls [17]. A cross-sectional sibling study
conducted in Singapore reported that KD-affected children
had more allergy and asthma than their non-KD affected
siblings [18]. These cross-sectional data suggest that KD. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cently, a case–control study found that KD patients were
more likely to have been admitted to hospital for asthma/
allergy than non-KD controls (OR = 2.6, 95% CI = 1.7-4.2)
[19]. These data suggest that these allergic diseases are
unlikely to reflect immune dysfunction resulting from KD
itself [19].
To our knowledge, despite several reports of condi-
tions associated with alergic diseases in KD patients
(cross-sectional or case–control designs), large sample
data regarding the exact incidence of allergic diseases
occurring in KD patients are still lacking. We undertook
the present study to determine the incidence of allergic
diseases in KD patients in Taiwan.
Methods
Data source
The National Health Insurance (NHI) program, which
provides compulsory universal health insurance, was
implemented in Taiwan on March 1, 1995. Under the
NHI, 98% of the island’s population receives all forms of
health care services including outpatient services, in-
patient care, Chinese medicine, dental care, childbirth,
physical therapy, preventive health care, home care, and
rehabilitation for chronic mental illness. In cooperation
with the Bureau of NHI, the National Health Research
Institute (NHRI) of Taiwan randomly sampled a represen-
tative database of 1,000,000 subjects from the entire NHI
enrollees by means of a systematic sampling method for
research purposes. There were no statistically significant
differences in age, gender, and healthcare costs between
the sample group and all enrollees, as reported by the
NHRI. This dataset (from January 1996 to December
2010) includes all claim data for these 1,000,000 subjects,
offers a good opportunity to examine the incidence of
allergic diseases occurring among patients with KD. These
databases have previously been used for epidemiological
research, and information on prescription use, diagnoses,
and hospitalizations has been shown to be of high quality
[20].
Because the identification numbers of all individuals in
the NHRI databases were encrypted to protect the priv-
acy of the individuals, this study was exempt from full
review by the Institution Review Board.
Study cohorts
From this database, we selected all children who were
5 years of age or younger and had a first-time
hospitalization with a diagnosis of KD (ICD-9-CM
code 446.1) between 1997 and 2005 (n = 378). We ex-
cluded subjects who had been hospitalized with a KD
before the year of 1997 (i.e., in 1996; because the NHI
program started in 1995, we were able to trace the
use of medical services only to 1996) to limit thestudy subjects to new cases (n = 31). We excluded
subjects who had been given a diagnosis of allergic
diseases including asthma (ICD-9 CM code 493.X) or
allergic rhinitis (ICD-9 CM code 477.X) prior to their
index ambulatory care visit (the date of a patient’s
hospitalization for KD) (n = 93). In total, 254 patients
with KD were included in the study group.
The comparison cohort was selected from the remaining
patients in the database. We first excluded patients who
had been diagnosed with KD during the period 1996–2010
and those older 5 years of age. Controls were also chosen
from 1997 to 2005. For each study cohort patient, 4 refer-
ence individuals were identified randomly and matched for
gender, age, and year of index ambulatory care visit. For
comparison cohort, the index ambulatory care visit was
their first ambulatory care visit occurring in the index year.
Of the 254 incident KD cases ascertained, no controls
could be found for one case. A total of 1,012 individuals
served as a comparison cohort group.
Potential confounders
For all individuals in the two cohorts, we obtained data
on potential confounders including age, gender, number
of physician visits 1 year before index date, the levels of
insurance as an economic index and urbanization level
of the community in which the patients resided. In
Taiwan, the urbanization levels are divided into 7 cat-
egories, ranging from category 1 (the most urbanized) to
category 7 (least urbanized), based on 5 indices: popula-
tion density, percentages of residents with college or
higher education, percentages of residents over 65 years
old, percentage of residents who were agricultural
workers, and the number of physicians per 100,000
people [21]. For the analyses, the urban–rural classifica-
tion was aggregated into 3 levels: I. urban (categories 1
and 2), II. suburban (categories 3 and 4), and III. rural
(categories 5, 6, and 7). All children were financially de-
pendents of the insured (the ones who paid the insur-
ance fee; i.e., usually the child’s parents, grandparents, or
social welfare institutions). We used the monthly income
of children’s enrollees as a proxy to measure of children’s
socioeconomic status.
Statistics
For comparisons of proportions between the study and
comparison cohorts, chi-square statistics were used. We
compared continuous data using the student t test. Each
patient was individually tracked for a 5-year period
starting from their cohort entry to identify whether the
patient had experienced allergic rhinitis or asthma dur-
ing the follow-up period. The person-years of follow-up
were calculated for each patient from the date of the co-
hort entry to the date of being diagnosed with allergic
diseases or the end of the study (a 5-year follow-up
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calculated by dividing the number of allergic diseases by
the total person-years of follow-up. Cox proportional
hazards regression models were used to estimate the
hazard ratios (HR) and 95% confidence intervals (CI) in
a multivariate model adjusting for the above-mentioned
potential confounders. The assumption of proportional
hazards was assessed by including an interaction term
between time and exposure (KD patients vs patients in
the comparison cohort) in the model, and the propor-
tional assumption was satisfied. Analyses were
performed using the SAS statistical package (version 9.2,
SAS Institute Inc., Cary, NC, USA). All statistical tests
were two-sided. Values of p < 0.05 were considered sta-
tistically significant.
Results
There were 253 patients in our KD cohort that were
compared with 1,012 selected matched controls. Table 1
presents the distribution of demographic characteristics
of the study subjects and controls. After matching for
sex and age, patients with KD had comparable charac-
teristics for monthly income of the insured and
urbanicity of residence of the health insurance enrolled.
However, patients with KD had more physician visit on
average than patients in the comparison cohort (22.42
times vs 15.31 times).
Table 2 shows the distribution of allergic diseases during
the 5-year follow-up periods for these two cohorts. Of the
total 1,265 sampled patients, 620 patients (49.01%) devel-
oped allergic diseases throughout the study periods, 148Table 1 Basic characteristics for KD patients versus the comp





Age (mean ± SD) 1.61 ± 1.20









Monthly income of children’s enrollee
NT$ < 18300 74 29.25
NT$ 18301-25199 76 30.04
NT$≥ 25200 103 40.71(58.50% of the KD patients) from the study cohort (with an
incidence rate of 184.66 per 1,000 person-years) and 472
(46.64%) from the comparison cohort (with an incidence
rate of 124.99 per 1,000 person-years). The log-rank test
showed that KD patients had significantly lower 5-year al-
lergic disease-free survival rates than patients in the com-
parison cohort (p < 0.001).
Table 2 also shows the crude and adjusted hazard ra-
tios (HR) for allergic diseases for the two groups. After
adjusting for potential confounders, the HR for asthma
for KD patients was 1.51 (95% CI = 1.17-1.95) compared
to patients in the comparison cohort. KD patients were
at a 1.30-fold risk for allergic rhinitis compared with
patients in comparison cohort (HR = 1.30, 95% CI =
1.04-1.62).
Discussion
To our knowledge, this is the first population-based co-
hort study to examine the relationship between KD and
the subsequent risk of allergic diseases (asthma and
allergic rhinitis). Previous studies used either cross-
sectional [16-18] or case–control designs [19] to investi-
gate the prevalence of asthma/allergic diseases in KD
patients and non-KD controls.
Previous studies reported that the majority of the in-
creased asthma and allergy admissions occurred prior to
the KD illness, suggesting that these allergy/asthma are
unlikely to reflect immune dysfunction resulting from
KD itself. It may also suggest that a distinct immune
phenotype may be associated with an increased risk of
both KD and asthma/allergy [19]. In the acute stage ofarison patients
Comparison patients (n = 1012)
n % p value
608 60.08 -
404 39.92
1.61 ± 1.20 -
15.31 ± 12.82 < 0.001










Table 2 Rates and hazard ratios of allergic disease KD
cohort compared to patients in comparison cohort







Person time (years) 3776.39 801.46
Incidencea 124.99 184.66
Crude HR (95% CI) 1.00 1.57 (1.20-1.92)
Adjusted HR (95% CI)b 1.00 1.52 (1.24-1.86)
Asthma
Yes 269 89
Person time (years) 4325.12 997.73
Incidencea 62.19 89.20
Crude HR (95% CI) 1.00 1.49 (1.16-1.92)
Adjusted HR (95% CI)b 1.00 1.51 (1.17-1.95)
Allergic rhinitis
Yes 388 119
Person time (years) 4064.97 922.37
Incidencea 95.45 129.02
Crude HR (95% CI) 1.00 1.39 (1.12-1.72)
Adjusted HR (95% CI)b 1.00 1.30 (1.04-1.62)
a per 1000 person-years.
b Adjustments are made for age, gender, and number of physician visits.
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increased release of human neutrophil elastase and
matrix metalloproteinases [23], and similar patterns may
be important in childhood asthma [24]. Polymorphisms
in the mannose-binding lectin (MBL) gene have been
reported to be associated with susceptibility to KD [25].
A role for MBL polymorphisms in susceptibility to
asthma and allergic disease has also been reported [26].
This suggests that immunogenetic variations in the in-
nate immune response may contribute to the shared risk
of KD and asthma/allergy [19].
In this population-based cohort study, we found that
KD patients were 1.52 times more likely than the com-
parison cohort to develope allergic diseases. These data
may reflect the immunological consequences of KD,
and/or an underlying susceptibility to both KD and
asthma/allergy. The investigation of children following
the KD illness does not differentiate between the two
possibilities.
The mechanisms by which KD may increase the risk of
future development of allergic diseases remain unclear.
The immune system is highly activated during KD with a
myriad of immunoregulatory changes including Th1 im-
mune related response (such as IFN-gamma, TNF-alpha,
IL-1, and IL-10) [27-29] and Th2 immune related re-
sponse (such as eosinophil, IL-4, IL-5 [30,31]. There is evi-
dence that the scar from prior BCG vaccination and thetuberculin skin test becomes inflated in patients during
acute KD and is a marker of Th1-mediated delayed hyper-
sensitivity reaction [32]. Thus, if KD is indeed a strong
Th1 trigger and Th1 is associated with a reduced risk of
allergic diseases, we would expect that children with KD
will have a lower risk of developing allergic diseases. Our
data did not provide support for this hygiene hypothesis,
where an inverse relationship between increased Th1 cell-
mediated inflammation (KD) and decreased Th2-cell me-
diated allergy is observed [33,34]. By contrast, we
observed a positive association between KD and the risk
of allergic diseases. The reasons for the differences in the
findings are unknown. KD results in an acute inflamma-
tion. It has been shown that infections (inflammations)
are able to alter the function of regulatory T cells [35].
Our finding of an increased risk of developing allergic dis-
eases following KD may therefore plausibly be related to
the effect of regulatory T cells. Clearly, more work will be
needed before the influence of immune activation of Th1/
Th2 on the risk of developing allergic diseases is
understood.
The major strength of our study is the use of a com-
puterized database, which is population based and is
highly representative and allows a clear observation of
the temporal relationship between KD and allergic dis-
eases. Because we included a national sample of KD pa-
tients between 1997 and 2005, and because the control
subjects in this study were selected from a simple ran-
dom sampling of insured general population, we can rule
out the possibility of selection bias.
Several limitations of the present study should be
noted. First, KD cases were identified using medical
diagnoses recorded in the claim database. Data on the
accuracy of KD discharge diagnoses is not available in
Taiwan. Potential inaccurate data in claims record
could also lead to possible misclassification of KD.
Given the comprehensiveness of the NHI database and
its previous use for incidence study for KD [12], we are
confident that the effect of misclassification of case sta-
tus on our results is most likely of minor importance.
Second, diagnoses of allergic diseases rely on adminis-
trative claims data may be less accurate than those
obtained according to standardized criteria and mis-
classification is possible. However, this misclassification
is likely to be nondifferential and therefore would tend
to underestimate rather than overestimate the true rela-
tive risk of alleric diseases among KD patients. Third,
any study investigating an increased incidence of one
disease (allergic disease) conditional on the diagnosis of
another disease (KD) in clinical settings may suffer
from detection bias. In this study, the fact that KD pa-
tients had more physician visit on average than patients
in the comparison cohort could make KD patients
more likely to have allergies diagnosed. In addition,
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eases in patients who had KD due to the fact that previ-
ous studies have shown the correlation between KD
and allergic disease [16-19]. Therefore, the possibility
that our findings have arisen from detection bias could
not be excluded. Fourth, although we adjusted for sev-
eral potential confounders in the statistical analysis, a
number of possible confounding variables, including
body mass index and family history of allergic diseases,
which are associated with allergic diseases were not in-
cluded in our database. Lastly, as with any observa-
tional study, residual confounding by unmeasured
factors which are different between case cohort and
comparison cohort is also possible.
Conclusion
In conclusion, this study is the first cohort study to in-
vestigate epidemiologic data for allergic diseases among
children after KD. Our study results provide evidence
that KD patients are at an increased risk for the develop-
ment of allergic diseases compared with the general
population.
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